Modeling symptoms of mental illness, in all their complexity, represents an unusually challenging task even by the standards of modern science. Some symptoms, in particular, receive less attention due to their difficult translation into measurable phenotypes in model organisms. However, recent studies are now providing insights into the less understood facets of this diverse range of disorders.
Flipping the Switch on Depression
Depression, the flip side of mania, commandeers significant attention from the research community, and the circuits implicated in its development are starting to be elucidated. However, the molecular mechanisms underlying the development of its crippling symptoms, and which could be pharmacological targeted, are still poorly understood. Hailan Hu and colleagues (Li et al. 2013 ) now describe a proteomic approach that provides insights into the molecular triggers associated with the function of the lateral habenula, one of the key brain regions associated with the pathophysiology of depression. Both in humans and rodents, the habenula becomes activated by aversive emotions, and in depressed individuals its activity is enhanced. Habenulae from rats with congenitally learned helplessness display a strong increase in b-calcium/calmodulin-dependent protein kinase type II (bCaMKII) expression, and manipulation of its levels was sufficient to modulate the depressive symptoms in rats. Further dissection of bCaMKII signaling pathways revealed that its activity increases the synaptic levels of the GluR1-type AMPA receptors causing neuronal hyperactivity. Therefore, the authors identified a powerful bidirectional determinant of habenula activity and of its behavioral output that may be exploited for new treatment strategies. Li, K., et al. (2013) . Science 341, 1016 Science 341, -1020 Pressing the ''Replay'' Button in Schizophrenia
Cognitive dysfunction contributes greatly to the debilitating symptoms of schizophrenia, but getting to the core of its mechanism has proven challenging. It has been postulated that impairment in information processing at the neural circuit level may underlie these symptoms, and Susumu Tonegawa and colleagues (Suh et al., 2013) now provide support for this hypothesis. To make their case, the authors studied a well-characterized mouse model of schizophrenia with a forebrain-specific knockout of calcineurin, a major brain phosphatase that has been associated with the disease in human populations. These mice exhibit characteristic behavioral deficits, including cognitive dysfunction, as well as previously characterized changes in synaptic plasticity. To detect disruption of information processing in the hippocampus, the brain structure critical for memory formation, the authors recorded neuronal activity during exploratory behaviors and restful states. It has been previously shown that replay of exploration-associated hippocampal activity that happens during resting is critical for memory consolidation and working memory function. The mutant mice displayed enhanced neuronal firing and a loss of a distinct pattern of activity considered important for the process of neuronal reactivation, suggesting that in this mouse model complex circuit dysfunction is associated with behavioral deficits. Therefore, abnormal memory reactivation may underlie the disordered thinking and memory problems that afflict schizophrenia patients. Suh, J., et al. (2013) . Neuron 80, [484] [485] [486] [487] [488] [489] [490] [491] [492] [493] .
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Calcineurin knockout mice are unable to use representations of sequences of future and past behaviors to consolidate memories and plan future actions. Image courtesy of Z. Vessal.
